For the heart

Clinical

Chloe Hava

March 6, 2000

References

Australian Government Australian Institute of Health and Welfare. Heart, stroke and vascular disease: Australian facts. 2024. At:
www.aihw.gov.au/reports/heart-stroke-vascular-diseases/hsvd-facts/contents/summary?__cf_chl_tk=rdBRmK8d0ESsnzGKoxqSoPhYhF5k0SQmw4_CJ9ue5W8-1739941894-1.0.1.1-RJSLYVVhq7aZmxXJ1v11vQsTEUjubu3_JSoRUz5Z8RQ
AusCVDRisk. Australian CVD risk calculator. 2023. At: https://www.cvdcheck.org.au/calculator
Yasuda S, Kaikita K, Akao M, et al. Antithrombotic therapy for atrial fibrillation with stable coronary disease. New Eng J Med 2019;381:1103–13. At: www.nejm.org/doi/full/10.1056/NEJMoa1904143

Pharmacist of the Year – Ammar Altayib MPS

Lifetime Achievement Award – David North OAM MPS

Early Career Pharmacist of the Year – Lily Pham MPS

Intern of the Year – Peter Figliuzzi

Could Australia follow suit?

What does the TGA advise?

Will GLP-1 RAs be subsidised for weight loss?

What could LGBTQIA+ discrimination look like in a pharmacy setting?

What’s the impact?

What makes a pharmacy a welcoming and safe environment for LGBTQIA+ patients?

What challenges do LGBTQIA+ pharmacists face in the workplace?

Does your pharmacy warrant a ‘Rainbow Tick’?

What’s changing?

When does this change come into effect?

What’s the reason for the change?

If I record in practice management software, do I need to do anything differently?

Will there be further changes to practice software after 1 March?

Will I need to do anything differently if I enter vaccination directly into AIR via PRODA?

Does this mean pharmacists need to ask about pregnancy for every vaccination event?

What impact does a Wegovy have on cardiovascular risk?

What makes a patient eligible for Wegovy for cardiovascular disease?

What other cardiovascular risk factors does Wegovy help to mitigate?

Has a submission been made to PBAC?

What are the benefits for high-risk CVD patients with multimorbidities?

How long should cardiovascular patients stay on Wegovy?

Should other cardiovascular medicines be titrated if Wegovy is initiated?

What do patients need to know about adverse effects?

What complimentary lifestyle advice should pharmacists provide?

Pharmacist of the Year – Ammar Altayib MPS

Lifetime Achievement Award – David North OAM MPS

Early Career Pharmacist of the Year – Lily Pham MPS

Intern of the Year – Peter Figliuzzi

Could Australia follow suit?

What does the TGA advise?

Will GLP-1 RAs be subsidised for weight loss?

What could LGBTQIA+ discrimination look like in a pharmacy setting?

What’s the impact?

What makes a pharmacy a welcoming and safe environment for LGBTQIA+ patients?

What challenges do LGBTQIA+ pharmacists face in the workplace?

Does your pharmacy warrant a ‘Rainbow Tick’?

What’s changing?

When does this change come into effect?

What’s the reason for the change?

If I record in practice management software, do I need to do anything differently?

Will there be further changes to practice software after 1 March?

Will I need to do anything differently if I enter vaccination directly into AIR via PRODA?

Does this mean pharmacists need to ask about pregnancy for every vaccination event?

What impact does a Wegovy have on cardiovascular risk?

What makes a patient eligible for Wegovy for cardiovascular disease?

What other cardiovascular risk factors does Wegovy help to mitigate?

Has a submission been made to PBAC?

What are the benefits for high-risk CVD patients with multimorbidities?

How long should cardiovascular patients stay on Wegovy?

Should other cardiovascular medicines be titrated if Wegovy is initiated?

What do patients need to know about adverse effects?

What complimentary lifestyle advice should pharmacists provide?

Pharmacist of the Year – Ammar Altayib MPS

Lifetime Achievement Award – David North OAM MPS

Early Career Pharmacist of the Year – Lily Pham MPS

Intern of the Year – Peter Figliuzzi

Could Australia follow suit?

What does the TGA advise?

Will GLP-1 RAs be subsidised for weight loss?

What could LGBTQIA+ discrimination look like in a pharmacy setting?

What’s the impact?

What makes a pharmacy a welcoming and safe environment for LGBTQIA+ patients?

What challenges do LGBTQIA+ pharmacists face in the workplace?

Does your pharmacy warrant a ‘Rainbow Tick’?

What’s changing?

When does this change come into effect?

What’s the reason for the change?

If I record in practice management software, do I need to do anything differently?

Will there be further changes to practice software after 1 March?

Will I need to do anything differently if I enter vaccination directly into AIR via PRODA?

Does this mean pharmacists need to ask about pregnancy for every vaccination event?

What impact does a Wegovy have on cardiovascular risk?

What makes a patient eligible for Wegovy for cardiovascular disease?

What other cardiovascular risk factors does Wegovy help to mitigate?

Has a submission been made to PBAC?

What are the benefits for high-risk CVD patients with multimorbidities?